Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Engelhardt

Showing results (11-20 of 226) with videos related to

Pageof 23
Sort By:
Frontiers in Genetics|July 14, 2022
The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and TherapyChristine Greil, Monika Engelhardt, Ralph Wäsch
Stem Cells (Dayton, Ohio)|January 17, 2003
CD34- hematopoietic stem cells: current concepts and controversiesYalin Guo, Michael Lübbert, Monika Engelhardt
Annals of Hematology|June 3, 2005
Successful treatment of a patient with myelodysplastic syndrome (RAEB) with Darbepoetin-alfa in combination with PegfilgrastimAndreas Jakob, Friedrich W Hirsch, Monika Engelhardt
Haematologica|May 3, 2022
Proteasome inhibition: the dawn of novel therapies in multiple myelomaMonika Engelhardt, Johannes Moritz Waldschmidt, Ralph Wäsch
Deutsche Medizinische Wochenschrift (1946)|June 7, 2018
[Infusion of Daratumumab in Combination Therapies - Practical Information for The Outpatient Area]Christof Scheid, Markus Munder, Hans Salwender, et al.
Deutsche Medizinische Wochenschrift (1946)|April 24, 2023
[Differences due to socio-economic status, genetic background and sex in cancer and precision medicine - An intersectional approach to close the care gap for marginalized groups]Monika Engelhardt, Annamaria Brioli, Marie von Lilienfeld-Toal
Deutsches Arzteblatt International|March 1, 2017
The Prevention of Medication-related Osteonecrosis of the JawPhilipp Poxleitner, Monika Engelhardt, Rainer Schmelzeisen, et al.
Haematologica|November 1, 2019
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?Monika Engelhardt, Kwee Yong, Sara Bringhen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
PomalidomideMonika Engelhardt, Ralph Wäsch, Heike Reinhardt, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2015
The Use of SNAP Labeling to Study Cell Cycle Oscillatory ProteinsChristine Greil, Marie Follo, Monika Engelhardt, et al.
Pageof 23

Showing results (11-20 of 226) with videos related to

Sort By:
Pageof 23
Frontiers in Genetics|July 14, 2022
The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and TherapyChristine Greil, Monika Engelhardt, Ralph Wäsch
Stem Cells (Dayton, Ohio)|January 17, 2003
CD34- hematopoietic stem cells: current concepts and controversiesYalin Guo, Michael Lübbert, Monika Engelhardt
Annals of Hematology|June 3, 2005
Successful treatment of a patient with myelodysplastic syndrome (RAEB) with Darbepoetin-alfa in combination with PegfilgrastimAndreas Jakob, Friedrich W Hirsch, Monika Engelhardt
Haematologica|May 3, 2022
Proteasome inhibition: the dawn of novel therapies in multiple myelomaMonika Engelhardt, Johannes Moritz Waldschmidt, Ralph Wäsch
Deutsche Medizinische Wochenschrift (1946)|June 7, 2018
[Infusion of Daratumumab in Combination Therapies - Practical Information for The Outpatient Area]Christof Scheid, Markus Munder, Hans Salwender, et al.
Deutsche Medizinische Wochenschrift (1946)|April 24, 2023
[Differences due to socio-economic status, genetic background and sex in cancer and precision medicine - An intersectional approach to close the care gap for marginalized groups]Monika Engelhardt, Annamaria Brioli, Marie von Lilienfeld-Toal
Deutsches Arzteblatt International|March 1, 2017
The Prevention of Medication-related Osteonecrosis of the JawPhilipp Poxleitner, Monika Engelhardt, Rainer Schmelzeisen, et al.
Haematologica|November 1, 2019
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?Monika Engelhardt, Kwee Yong, Sara Bringhen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
PomalidomideMonika Engelhardt, Ralph Wäsch, Heike Reinhardt, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2015
The Use of SNAP Labeling to Study Cell Cycle Oscillatory ProteinsChristine Greil, Marie Follo, Monika Engelhardt, et al.
Pageof 23